"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
Descriptor ID |
D015996
|
MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 56 | 56 |
1995 | 0 | 79 | 79 |
1996 | 0 | 83 | 83 |
1997 | 0 | 51 | 51 |
1998 | 0 | 73 | 73 |
1999 | 0 | 98 | 98 |
2000 | 0 | 77 | 77 |
2001 | 0 | 97 | 97 |
2002 | 0 | 98 | 98 |
2003 | 1 | 131 | 132 |
2004 | 0 | 106 | 106 |
2005 | 0 | 150 | 150 |
2006 | 0 | 170 | 170 |
2007 | 0 | 186 | 186 |
2008 | 0 | 171 | 171 |
2009 | 0 | 169 | 169 |
2010 | 1 | 217 | 218 |
2011 | 2 | 240 | 242 |
2012 | 2 | 207 | 209 |
2013 | 2 | 197 | 199 |
2014 | 3 | 191 | 194 |
2015 | 0 | 227 | 227 |
2016 | 1 | 249 | 250 |
2017 | 1 | 301 | 302 |
2018 | 1 | 247 | 248 |
2019 | 2 | 269 | 271 |
2020 | 0 | 217 | 217 |
2021 | 0 | 145 | 145 |
2022 | 0 | 33 | 33 |
2023 | 0 | 18 | 18 |
2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2606.
-
Systematic review of mortality and survival rates for APDS. Clin Exp Med. 2024 Jan 27; 24(1):17.
-
Pancreatic Cancer Action Network's SPARK: A Cloud-Based Patient Health Data and Analytics Platform for Pancreatic Cancer. JCO Clin Cancer Inform. 2024 Jan; 8:e2300119.
-
Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2547-2556.
-
Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit. Ann Surg Oncol. 2024 Jan; 31(1):614-621.
-
Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2024 01; 293:403-412.
-
Utility of Circulating Tumor DNA in Appendiceal Tumors. J Gastrointest Surg. 2023 Dec; 27(12):3071-3073.
-
Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms. Ann Surg Oncol. 2023 Dec; 30(13):8138-8143.
-
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. Ann Surg Oncol. 2023 Nov; 30(12):7840-7847.
-
Geographic Disparity of Outcome in Patients With Cancer Over Decades: The Surveillance, Epidemiology, and End Results. Clin Lymphoma Myeloma Leuk. 2023 11; 23(11):e369-e378.